MVM
Medicxi Ventures Management Portfolio holdings
AUM
$427M
This Quarter Return
+1.54%
1 Year Return
+42.94%
3 Year Return
+262.94%
5 Year Return
+109.92%
10 Year Return
–
AUM
$427M
AUM Growth
+$427M
(-2.4%)
Cap. Flow
-$156M
Cap. Flow
% of AUM
-36.62%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
RAPT Therapeutics
RAPT
|
$156M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
1
Centessa Pharmaceuticals
CNTA
$2.25B
| $262M | 61.4% | 19,963,157 | – | – |
|
2
Phathom Pharmaceuticals
PHAT
$864M
| $71.6M | 16.75% | 7,464,572 | – | – |
|
3
NewAmsterdam Pharma
NAMS
$2.71B
| $52M | 12.16% | 2,869,565 | – | – |
|
|
4
RAPT Therapeutics
RAPT
$188M
| $22.4M | 5.23% | 2,794,000 -19,558,000 | -88% | -$156M |
|
5
Aura Biosciences
AURA
$389M
| $19M | 4.45% | 3,039,892 | – | – |
|